From pulsed-field ablation to noninvasive monitoring, this was an exciting year for cardiac device tech. Here are the top 10 cardiac device stories from MassDevice and its sister sites: 10. Medtronic to pay Acutus $17M following EU MDR submission of left-heart access portfolio Earlier this year, Acutus agreed to sell its left-heart access portfolio to […]
Cordis
Cordis names Alan Tsai as GM of Greater China region
Cordis today announced it appointed Alan Tsai as general manager of its Greater China region. Tsai will head the leadership team that is responsible for strategic planning, business operation and team development in the Greater China region. He will be based in Shanghai and report directly to Bryan Loo, President of Cordis Asia Pacific. Tsai […]
Cordis to acquire MedAlliance for initial $235M
Cordis this week announced it will acquire MedAlliance for a total consideration of over $1 billion. Through the deal, Cordis will pay an initial investment of $35 million and an upfront closing payment of $200 million. In addition, it will pay regulatory achievement milestones of up to $125 million. Plus, commercial milestone payments could reach […]
Cordis begins enrollment in study of lesion treatment
Cordis announced that it began the Radiancy pre-market clinical study of its vascular stent system for treating lesions. Miami Lakes, Florida-based Cordis’ prospective, multi-center, single-arm study in Europe will assess the safety and efficacy of the SMART Radianz vascular stent system for the treatment of lesions in the iliac, superficial femoral or proximal popliteal arteries […]
Cordis among those investing $15M in Endovascular Engineering
Endovascular Engineering today announced the closing of a $15 million Series A1 financing co-led by Santé Ventures and Cordis. The Menlo Park, California–based startup is also called E2. It’s focused on developing advanced mechanical thrombectomy technology. Get the full story on our sister site Medical Tubing + Extrusion.
InnovHeart appoints former J&J executive as CEO
InnovHeart this week announced that it appointed medtech veteran David Wilson as CEO. Wilson has more than 30 years of experience in medical device industry. He previously served in numerous leadership roles at Johnson & Johnson, including worldwide president of Cordis. Wilson has also served at J&J as president of Mentor, VP of Ethicon R&D […]
Cordis names new CFO
Cordis today announced that it has appointed Christopher Scully as chief financial officer. Scully will lead the interventional cardiovascular technology company’s financial and IT functions to accelerate Cordis’s growth. Before joining the company, Scully was executive VP and CFO for PPD. He played a role in the company’s IPO and its eventual sale to Thermo […]
Cordis names new chief medical officer
Cardiovascular technology developer Cordis announced today that it appointed Dr. George Adams as its new chief medical officer. Miami Lakes, Florida-based Cordis said in a news release that the hiring of Adams furthers its mission to differentiate itself as a technological leader and value-based global medical device company. “We are delighted to have Dr. Adams […]
Cordis recalls some Smart Flex vascular stent systems
Cordis recently issued a warning letter regarding an issue with its Smart Flex vascular stent system. Santa Clara, California–based Cordis’s field safety correction action informs users that some of its Smart Flex vascular stents have the potential for distal tip dislodgment or separation due to inadequate adhesive application. Get the full story on our sister […]
Cardinal Health completes $1B sale of Cordis business
Cardinal Health (NYSE: CAH) announced today that it has completed the sale of its Cordis business to private equity firm Hellman & Friedman. The $1 billion sales price included includes H&F’s assumption of certain liabilities and Cardinal Health’s retention of some working capital accounts. “As we shared previously, this divestiture demonstrates our disciplined portfolio evaluation […]
FDA says Cordis carotid artery stent recall is serious
The FDA has classified Cordis‘ recall of its Precise Pro Rx carotid system as Class I, the most serious kind of recall. Cordis in February recalled certain lots of its Precise Pro RX carotid stent systems because of a risk of separation of the atraumatic distal tip of the sheathed delivery system in patients. The […]
